Our investigation strongly supported the anti-inflammatory effects of sevoflurane in ALI: sevoflurane improved LPS-induced ALI in vivo by improving lung histological alteration, decreasing inflammatory cytokine levels in BALF, and inhibiting TLR4 gene and protein expressions in lung tissue. The gene discussed is TLR4; the disease is acute respiratory distress syndrome.